Scrip is part of Pharma Intelligence UK Limited
This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.
Rubius Therapeutics Inc. (cell therapies) raised $101.2mm in an oversubscribed Series C financing. According to the Form D, 27 investors participated. The company is developing Red-Cell Therapeutics (RCT) allogeneic products with extended stability and storage. Rubius will use the funds to move RTC therapies into the clinic and enhance its manufacturing capabilities.
Gene Therapy, Cell Therapy
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?